In a male patient with ADHD and oppositional defiant disorder living in a foster care facility who reports that his amphetamine/dextroamphetamine extended‑release (25 mg) capsule wears off before the end of the day, how should his stimulant regimen be adjusted to achieve full‑day symptom control?

Adjusting Amphetamine/Dextroamphetamine ER for Wear-Off Symptoms

Add an afternoon immediate-release amphetamine/dextroamphetamine dose of 5-10 mg (starting at 5 mg) to extend symptom control through the end of the day, rather than increasing the morning extended-release dose. 1

Rationale for Afternoon Supplementation

The current 25 mg ER dose is within the therapeutic range (maximum 40 mg/day for amphetamines) 1, so the issue is likely duration of coverage rather than inadequate total dosing. Extended-release amphetamine formulations typically provide 10-12 hours of coverage 1, but individual pharmacokinetics vary, and some patients experience symptom return before day's end—particularly problematic in foster care settings where evening behavioral control is crucial for both the patient and caregivers.

The guideline-recommended approach is to add a third (afternoon/PM) dose rather than simply increasing the morning dose 1. This strategy:

• Extends coverage into homework time and evening activities
• Avoids excessive peak levels from a single large morning dose
• Allows flexible timing based on when symptoms return

Specific Dosing Algorithm

1. Start with 5 mg immediate-release amphetamine/dextroamphetamine given 4-6 hours after the morning ER dose (typically early-to-mid afternoon) 1

2. Titrate the afternoon dose in 2.5-5 mg increments weekly if needed, up to 10 mg 1

3. Monitor total daily dose: Current 25 mg + afternoon supplement should not exceed 40 mg total daily without clear documentation of need and absence of side effects 1

4. Time the afternoon dose carefully: Give early enough to avoid insomnia (typically no later than 4-5 PM) but late enough to cover homework and evening activities 1

Important Caveats for This Population

Foster care setting considerations:

• Ensure medication administration supervision for both morning and afternoon doses—foster care facilities must maintain locked storage and dispensing records 1
• The ODD comorbidity increases risk of medication diversion or non-adherence; structured administration is essential
• Document that behavioral improvements justify the additional dose, as oppositional behaviors may be misattributed to medication wear-off

Monitor for:

• Insomnia: If sleep onset is delayed, move the afternoon dose earlier or reduce it 1
• Appetite suppression: Ensure high-calorie snacks/meals when medication effects wear off in evening 1
• Behavioral rebound: Irritability when medication wears off—this actually supports the need for afternoon dosing 1
• Weight and growth: Monthly monitoring in maintenance phase 1

Alternative if Afternoon Dosing Fails

If adding an afternoon IR dose proves impractical in the foster care setting (administration difficulties, compliance issues), consider switching to a longer-acting amphetamine formulation. Evidence suggests that increasing the morning dose of amphetamine ER may extend duration of action 1, so you could trial increasing to 30 mg ER once daily before adding the afternoon dose—though this is less preferred than the split-dosing approach.

The key distinction: Don't just increase the morning ER dose first. The guidelines clearly favor adding an afternoon dose to extend coverage 1, and this approach better addresses the specific complaint of end-of-day wear-off while minimizing side effects.